Overview of MK-7602 and Why It Matters Researchers have unveiled a first-in-class antimalarial candidate, MK-7602, designed to confront the growing problem of drug resistance and potentially reduce malaria transmission. The program represents a strategic pivot in the field, aiming to deliver a drug with a unique mechanism of action that can stay effective as parasites…